Okay, let's tackle this question about case-control versus cohort studies. The question is asking which aspect case-control studies are better than cohort studies. First, I need to recall the key differences between these two types of epidemiological studies.

Case-control studies are retrospective, meaning they start with the outcome (disease) and look back at exposures. Cohort studies are prospective, following a group over time to see who develops the disease. The main advantage of case-control studies is their efficiency in studying rare diseases because you don't need a large population to observe enough cases. Cohort studies might require a huge sample size for rare diseases, making them less feasible.

Now, looking at the options. The correct answer is likely related to cost or time efficiency. Let's say the options are about feasibility for rare diseases, better for common diseases, higher accuracy in determining causality, or something else.

If the options are A: Rare diseases, B: Common diseases, C: Cost, D: Time. Then case-control is better for rare diseases (A) because you can select cases with the disease and controls without it, making it more efficient. Cohort studies would need a massive population to find enough cases, which is impractical. So the correct answer would be A.

The other options: Cohort is better for common diseases (B is wrong). Case-control is cheaper than cohort (C might be correct, but the question is about which aspect it's better, so maybe the key is rare diseases). Time-wise, case-control is faster (D is also a point, but again, the primary advantage is studying rare diseases). So the answer is A.

**Core Concept**
Case-control studies are observational, retrospective designs ideal for investigating rare diseases or outcomes with long latency periods. They compare individuals with a disease (cases) to those without (controls) to identify past exposure differences, contrasting with cohort studies that track exposures prospectively.

**Why the Correct Answer is Right**
Case-control studies are more efficient for studying **rare diseases** because they start by selecting individuals with the disease (cases) and matching controls without it. This avoids the impracticality of following a massive cohort for years to observe a rare outcome. They require fewer resources and time, making them cost-effective for rare conditions like certain cancers or genetic disorders.

**Why Each Wrong Option is Incorrect**
**Option B:** Cohort studies excel in studying common diseases due to their ability to establish temporal relationships and calculate incidence rates.
**Option C:** Cohort studies are more accurate for determining causality as they follow exposures before outcome occurrence, minimizing recall bias.
**Option D:** While case-control studies are faster and cheaper than cohort studies, this is not their defining advantage over cohort studies in all contexts—only in specific scenarios like rare diseases.

**Clinical Pearl / High-Yield Fact**
Use case-control studies for **rare diseases** or when exposure data is hard to collect. Remember: "Cases first, then controls" vs. "Cohort follows exposure first." Avoid using case-control studies for rare exposures, as they require large control groups.

**Correct Answer: A. Rare diseases**

✓ Correct Answer: C. Shorter duration